-
PATHOL RES PRACT 2024 10.1016/j.prp.2023.155063
Comparative analysis of ARID1A mutations with mRNA levels and protein expression in gastric carcinoma
Hwang, I; Cho, Y; Kang, SY; Kim, DG; Ahn, S; Lee, J; Kim, KM
View PubMed
-
YONSEI MED J 2023 10.3349/ymj.2023.0161
The First Korean Adult Case of Progressive Familial Intrahepatic Cholestasis Type 7 with Novel USP53 Splicing Variants by Next Generation Sequencing
Ahn, S; Choi, J; Jeong, SH
View PubMed
-
HISTOPATHOLOGY 2023 10.1111/his.15081
Multiregional analysis of combined hepatocellular-cholangiocarcinoma reveals histologic diversity and molecular clonality
Na, HY; Kim, JH; Kim, H; Cho, JY; Han, HS; Jang, ES; Kim, JW; Jeong, SH; Heo, J; Kim, JW; Kim, JW; Ahn, S
View PubMed
-
CANCER MED-US 2023 10.1002/cam4.6472
Impact of programmed death-ligand 1 (PD-L1) positivity on clinical and molecular features of patients with metastatic gastric cancer
Shin, M; Ahn, S; Jung, J; Hyung, S; Kim, KM; Kim, ST; Kang, WK; Lee, J
View PubMed
-
J PATHOL 2023 10.1002/path.6134
PIK3CA mutation subtype delineates distinct immune profiles in gastric carcinoma
Choi, S; Kim, H; Heo, YJ; Kang, SY; Ahn, S; Lee, JY; Kim, KM
View PubMed
-
ANN DERMATOL 2023 10.5021/ad.21.060
Dual Biological Therapy for Ulcerative Colitis with Intractable Pyoderma Gangrenosum
Lee, HC; Kwon, Y; Kim, ES; Ahn, S; Choe, YH; Kim, MJ
View PubMed
-
CANCERS 2023 10.3390/cancers15061656
Prognostic Significance of Esophagogastric Junction Invasion in Patients with Adenocarcinoma of the Cardia or Subcardia
Oh, SE; Park, S; Ahn, S; An, JY; Lee, JH; Sohn, TS; Bae, JM; Choi, MG
View PubMed
-
J GASTRIC CANCER 2023 10.5230/jgc.2023.23.e7
A Standardized Pathology Report for Gastric Cancer: 2nd Edition
Park, YS; Kook, MC; Kim, BH; Lee, HS; Kang, DW; Gu, MJ; Shin, OR; Choi, Y; Lee, W; Kim, H; Song, IH; Kim, KM; Kim, HS; Kang, G; Park, DY; Jin, SY; Kim, JM; Choi, YJ; Chang, HK; Ahn, S; Chang, MS; Han, SH; Kwak, Y; Seo, AN; Lee, SH; Cho, MY
View PubMed
-
ELIFE 2022 10.7554/eLife.78636
Gallbladder adenocarcinomas undergo subclonal diversification and selection from precancerous lesions to metastatic tumors
Kang, M; Na, HY; Ahn, S; Kim, JW; Lee, S; Ahn, S; Lee, JH; Youk, J; Kim, HT; Kim, KJ; Suh, KJ; Lee, JS; Kim, SH; Kim, JW; Kim, YJ; Lee, KW; Yoon, YS; Kim, JH; Chung, JH; Han, HS; Lee, JS
View PubMed
-
PATHOL ONCOL RES 2022 10.3389/pore.2022.1610697
MET gene alterations predict poor survival following chemotherapy in patients with advanced cancer
Ko, J; Jung, J; Kim, ST; Hong, JY; Park, S; Park, JO; Park, YS; Lim, HY; Ahn, S; Kim, KM; Kang, WK; Lee, J
View PubMed
-
DIAGNOSTICS 2022 10.3390/diagnostics12102355
Peritoneal Seeding Is More Common in Gastric Cancer Patients with FGFR2 Amplification or High Tumor Mutation Burden
Kim, H; Park, S; Kang, SY; Ahn, S; Kim, KM
View PubMed
-
PATHOL RES PRACT 2022 10.1016/j.prp.2022.154108
Gastric cancer with Epstein-Barr virus heterogeneity: Evaluation of the frequency, clinicopathologic features, and genomic profiles
Kim, HN; Ahn, S; Kim, KM
View PubMed
-
PATHOL RES PRACT 2022 10.1016/j.prp.2022.153874
Comparative analysis of microsatellite instability by next-generation sequencing, MSI PCR and MMR immunohistochemistry in 1942 solid cancers
Kang, SY; Kim, DG; Ahn, S; Ha, SY; Jang, KT; Kim, KM
View PubMed
-
BIOMEDICINES 2022 10.3390/biomedicines10030543
Gastric Cancer: Mechanisms, Biomarkers, and Therapeutic Approaches
Choi, S; Park, S; Kim, H; Kang, SY; Ahn, S; Kim, KM
View PubMed
-
CANCER GENOM PROTEOM 2022 10.21873/cgp.20307
High Frequency of Juxtamembrane Domain ERBB2 Mutation in Gastric Cancer
Park, S; Ahn, S; Kim, DG; Kim, H; Kang, SY; Kim, KM
View PubMed
-
FRONT ONCOL 2021 10.3389/fonc.2021.792340
The Impact of Tumor Mutation Burden on the Effect of Frontline Trastuzumab Plus Chemotherapy in Human Epidermal Growth Factor Receptor 2-Positive Advanced Gastric Cancers
Kim, HR; Ahn, S; Jo, H; Kim, H; Hong, J; Lee, J; Lim, HY; Kang, WK; Kim, ST
View PubMed
-
CLIN TRANSL ONCOL 2021 10.1007/s12094-021-02714-6
Tumor immune microenvironment is influenced by frameshift mutations and tumor mutational burden in gastric cancer
Kim, H; Heo, YJ; Cho, YA; Kang, SY; Ahn, S; Kim, KM
View PubMed
-
CANCERS 2021 10.3390/cancers13174454
Clinical Impact of Unexpected Para-Aortic Lymph Node Metastasis in Surgery for Resectable Pancreatic Cancer
Lee, HK; Yoon, YS; Han, HS; Lee, JS; Na, HY; Ahn, S; Park, J; Jung, K; Jung, JH; Kim, J; Hwang, JH; Lee, JC
View PubMed
-
SCI REP-UK 2021 10.1038/s41598-021-98857-1
Deep learning-based virtual cytokeratin staining of gastric carcinomas to measure tumor-stroma ratio
Hong, Y; Heo, YJ; Kim, B; Lee, D; Ahn, S; Ha, SY; Sohn, I; Kim, KM
View PubMed
-
J CANCER RES CLIN 2021 10.1007/s00432-021-03781-6
The prevalence of homologous recombination deficiency (HRD) in various solid tumors and the role of HRD as a single biomarker to immune checkpoint inhibitors
Kim, H; Ahn, S; Kim, H; Hong, JY; Lee, J; Park, SH; Park, JO; Park, YS; Lim, HY; Kang, WK; Kim, KM; Kim, ST
View PubMed
-
FRONT IMMUNOL 2021 10.3389/fimmu.2021.698721
Needs for Increased Awareness of Gastrointestinal Manifestations in Patients With Human Inborn Errors of Immunity
Kim, ES; Kim, D; Yoon, Y; Kwon, Y; Park, S; Kim, J; Ahn, KM; Ahn, S; Choe, YH; Kim, YJ; Kim, MJ
View PubMed
-
J BREAST CANC 2021 10.4048/jbc.2021.24.e29
Programmed Death Ligand 1 Immunohistochemistry in Triple-Negative Breast Cancer: Evaluation of Inter-Pathologist Concordance and Inter-Assay Variability
Ahn1, S; Woo, JW; Kim, H; Cho, EY; Kim, A; Kim, JY; Kim, C; Lee, HJ; Lee, JS; Bae, YK; Kwon, Y; Kim, WS; Park, SY
View PubMed
-
AM J SURG PATHOL 2021 10.1097/PAS.0000000000001651
Gastric Inverted Polyps-Distinctive Subepithelial Lesions of the Stomach Clinicopathologic Analysis of 12 Cases With an Emphasis on Neoplastic Potential
Kim1, JY; Ahn, S; Kim, KM; Chang, SH; Kim, HS; Lee, JH; Kim, JJ; Sohn, TS; Kang, HJ; Joo, M
View PubMed
-
MODERN PATHOL 2021 10.1038/s41379-021-00823-9
PD-L1 expression in gastric cancer: interchangeability of 22C3 and 28-8 pharmDx assays for responses to immunotherapy
Ahn1, S; Kim, KM
View PubMed
-
PATHOL ONCOL RES 2021 10.3389/pore.2021.604600
The Clinicopathological Significance of YAP/TAZ Expression in Hepatocellular Carcinoma with Relation to Hypoxia and Stemness
Park1, H; Lee, Y; Lee, K; Lee, H; Yoo, JE; Ahn, S; Park, YN; Kim, H
View PubMed
-
CANCERS 2020 10.3390/cancers12082128
The Clinicopathological and Prognostic Significance of Nrf2 and Keap1 Expression in Hepatocellular Carcinoma
Lee1, K; Kim, S; Lee, Y; Lee, H; Lee, Y; Park, H; Nahm, JH; Ahn, S; Yu, SJ; Lee, K; Kim, H
View PubMed
-
PATHOL RES PRACT 2020 10.1016/j.prp.2019.152734
Correlation between RICTOR overexpression and amplification in advanced solid tumors
Bang1, H; Ahn, S; Kim, EJ; Kim, ST; Park, H; Lee, J; Kim, KM
View PubMed
